These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37020233)

  • 1. Optimizing communication strategies and designing a comprehensive program to facilitate cascade testing for familial hypercholesterolemia.
    Campbell-Salome G; Jones LK; Walters NL; Morgan KM; Brangan A; Ladd IG; McGowan MP; Wilemon K; Schmidlen TJ; Simmons E; Schwartz MLB; McMinn MN; Tricou E; Rahm AK; Ahmed CD; Sturm AC
    BMC Health Serv Res; 2023 Apr; 23(1):340. PubMed ID: 37020233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing and Optimizing Innovative Tools to Address Familial Hypercholesterolemia Underdiagnosis: Identification Methods, Patient Activation, and Cascade Testing for Familial Hypercholesterolemia.
    Campbell-Salome G; Jones LK; Masnick MF; Walton NA; Ahmed CD; Buchanan AH; Brangan A; Esplin ED; Kann DG; Ladd IG; Kelly MA; Kindt I; Kirchner HL; McGowan MP; McMinn MN; Morales A; Myers KD; Oetjens MT; Rahm AK; Schmidlen TJ; Sheldon A; Simmons E; Snir M; Strande NT; Walters NL; Wilemon K; Williams MS; Gidding SS; Sturm AC
    Circ Genom Precis Med; 2021 Feb; 14(1):e003120. PubMed ID: 33480803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Motivating cascade testing for familial hypercholesterolemia: applying the extended parallel process model for clinician communication.
    Campbell-Salome G; Walters NL; Ladd IG; Sheldon A; Ahmed CD; Brangan A; McMinn MN; Rahm AK; Schwartz MLB; Tricou E; Fisher CL; Sturm AC
    Transl Behav Med; 2022 Jul; 12(7):800-809. PubMed ID: 35429393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Web-Based Tool (FH Family Share) to Increase Uptake of Cascade Testing for Familial Hypercholesterolemia: Development and Evaluation.
    Bangash H; Makkawy A; Gundelach JH; Miller AA; Jacobson KA; Kullo IJ
    JMIR Hum Factors; 2022 Feb; 9(1):e32568. PubMed ID: 35166678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perspectives from individuals with familial hypercholesterolemia on direct contact in cascade screening.
    Schwiter R; Brown E; Murray B; Kindt I; Van Enkevort E; Pollin TI; Sturm AC
    J Genet Couns; 2020 Dec; 29(6):1142-1150. PubMed ID: 32223038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Designing implementation strategies to improve identification, cascade testing, and management of families with familial hypercholesterolemia: An intervention mapping approach.
    Jones LK; Calvo EM; Campbell-Salome G; Walters NL; Brangan A; Rodriguez G; Ahmed CD; Morgan KM; Gidding SS; Williams MS; Brownson RC; Seaton TL; Goldberg AC; McGowan MP; Rahm AK; Sturm AC
    Front Health Serv; 2023; 3():1104311. PubMed ID: 37188259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Family cascade screening for equitable identification of familial hypercholesterolemia: study protocol for a hybrid effectiveness-implementation type III randomized controlled trial.
    Johnson C; Chen J; McGowan MP; Tricou E; Card M; Pettit AR; Klaiman T; Rader DJ; Volpp KG; Beidas RS
    Implement Sci; 2024 Apr; 19(1):30. PubMed ID: 38594685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative cascade-testing protocols for identifying and managing patients with familial hypercholesterolaemia: systematic reviews, qualitative study and cost-effectiveness analysis.
    Qureshi N; Woods B; Neves de Faria R; Saramago Goncalves P; Cox E; Leonardi Bee J; Condon L; Weng S; Akyea RK; Iyen B; Roderick P; Humphries SE; Rowlands W; Watson M; Haralambos K; Kenny R; Datta D; Miedzybrodzka Z; Byrne C; Kai J
    Health Technol Assess; 2023 Oct; 27(16):1-140. PubMed ID: 37924278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Testing for Familial Hypercholesterolemia: Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2022; 22(3):1-155. PubMed ID: 36158868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of cascade testing strategies in relatives for familial hypercholesterolemia: A systematic review and meta-analysis.
    Leonardi-Bee J; Boateng C; Faria R; Eliman K; Young B; Qureshi N
    Atherosclerosis; 2021 Dec; 338():7-14. PubMed ID: 34753031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acceptability, Appropriateness, and Feasibility of Automated Screening Approaches and Family Communication Methods for Identification of Familial Hypercholesterolemia: Stakeholder Engagement Results from the IMPACT-FH Study.
    Jones LK; Walters N; Brangan A; Ahmed CD; Gatusky M; Campbell-Salome G; Ladd IG; Sheldon A; Gidding SS; McGowan MP; Rahm AK; Sturm AC
    J Pers Med; 2021 Jun; 11(6):. PubMed ID: 34205662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Communicating risk with relatives in a familial hypercholesterolemia cascade screening program: a summary of the evidence.
    Allison M
    J Cardiovasc Nurs; 2015; 30(4):E1-E12. PubMed ID: 24831729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic Testing for Familial Hypercholesterolemia in Clinical Practice.
    Tricou EP; Morgan KM; Betts M; Sturm AC
    Curr Atheroscler Rep; 2023 May; 25(5):197-208. PubMed ID: 37060538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient acceptance of genetic testing for familial hypercholesterolemia in the CASCADE FH Registry.
    Gidding SS; Sheldon A; Neben CL; Williams HE; Law S; Zhou AY; Wilemon K; Ahmed CD; Kindt I
    J Clin Lipidol; 2020; 14(2):218-223.e2. PubMed ID: 32143996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients' perceptions and experiences of familial hypercholesterolemia, cascade genetic screening and treatment.
    Hardcastle SJ; Legge E; Laundy CS; Egan SJ; French R; Watts GF; Hagger MS
    Int J Behav Med; 2015 Feb; 22(1):92-100. PubMed ID: 24585182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of Measuring Lipoprotein(a) During Cascade Testing for Familial Hypercholesterolemia.
    Ellis KL; Pérez de Isla L; Alonso R; Fuentes F; Watts GF; Mata P
    J Am Coll Cardiol; 2019 Mar; 73(9):1029-1039. PubMed ID: 30846097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry.
    O'Brien EC; Roe MT; Fraulo ES; Peterson ED; Ballantyne CM; Genest J; Gidding SS; Hammond E; Hemphill LC; Hudgins LC; Kindt I; Moriarty PM; Ross J; Underberg JA; Watson K; Pickhardt D; Rader DJ; Wilemon K; Knowles JW
    Am Heart J; 2014 Mar; 167(3):342-349.e17. PubMed ID: 24576518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Communicating familial hypercholesterolemia genetic information within families.
    Maxwell SJ; Molster CM; Poke SJ; O'Leary P
    Genet Test Mol Biomarkers; 2009 Jun; 13(3):301-6. PubMed ID: 19473077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Case Detection by Cascade Testing in Familial Hypercholesterolemia: A Systematic Review of the Literature.
    Lee C; Rivera-Valerio M; Bangash H; Prokop L; Kullo IJ
    Circ Genom Precis Med; 2019 Nov; 12(11):e002723. PubMed ID: 31638829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evaluation of cascade testing for familial hypercholesterolemia.
    Morris JK; Wald DS; Wald NJ
    Am J Med Genet A; 2012 Jan; 158A(1):78-84. PubMed ID: 22139944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.